Clinical settingPatients with confirmed non-malignant ascites or malignancy related ascites (confirmed by ultrasound, CT, autopsy or follow-up).
Participants and Country99 patients. Germany
Study designRetrospective series
Target conditionMalignant ascites versus non-malignant ascites. Reference standard was ultrasound, CT, autopsy or clinical follow-up.
Follow upNot reported.
Propotion of patients with malignancy54/99, 55%
Pathology techniquesSample was centrifuged then the sediment was smeared and stained with Papanicolaou and Giesma stains. Immunohistochemistry (CEA). Other lab tests: cholesterol, LDH, fibronectin, albumin gradient, total protein.

From: Guideline chapter 2, Diagnosis

Cover of Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
NICE Clinical Guidelines, No. 104.
National Collaborating Centre for Cancer (UK).
Copyright © 2010, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.